Mount Sinai Alzheimers Disease Expert Receives Lifetime Achievement Award
Alison M. Goate, PhD, Professor of Neuroscience, Genetics and Genomic Sciences and Neurology for the Mount Sinai Health System and Director of the Ronald M. Loeb Center for Alzheimer’s Disease at the Icahn School of Medicine at Mount Sinai, has received the Khalid Iqbal, PhD, Lifetime Achievement Award in Alzheimer’s Disease Research for the Alzheimer’s Association. The award was presented on July 19 during the opening session at the Alzheimer’s Association Conference ® 2015 (AAIC ® 2015) in Washington, DC. Dr. Goate received the award for her contribution to advancing Alzheimer’s disease and dementia research.
The AAIC Lifetime Achievement Awards honor individuals who have made significant fundamental contributions to Alzheimer’s research, either through a single specific scientific discovery or a body of work. These contributions, whether they have been in research, leadership or mentorship, must have a lasting impact on the field and must demonstrate a lifetime commitment towards progress against Alzheimer’s and dementia.
“We are so proud of Dr. Goate and congratulate her for this outstanding honor,” said Eric J. Nestler, MD, PhD, Nash Family Professor and Chair of the Department of Neuroscience and Director of the Friedman Brain Institute in the Icahn School of Medicine at Mount Sinai. “Her internationally-recognized research to elucidate the genetic, molecular and cellular basis of Alzheimer’s disease and related dementias has added greatly to our understanding of these conditions. Under her leadership, Mount Sinai is playing a leading role in finding better treatments for Alzheimer’s and other disorders.”
Dr. Goate has worked on the genetics of Alzheimer’s disease for 27 years. She reported the first genetic mutation discovered that causes an inherited form of Alzheimer’s. She co-led the team of researchers that reported on some of the first disease-causing genetic mutations discovered for frontotemporal dementia. Her current research focuses on understanding the genetic risk factors for the more common, late-onset form of Alzheimer’s disease.
“It is a great honor to receive this award from my peers in the Alzheimer’s disease research community,” said Dr. Goate. “This work has been a team effort over several decades, so this award recognizes the efforts of all of those individuals as well.”
The Alzheimer’s Association is the leading voluntary health organization in Alzheimer’s care, support and research. They are committed to accelerating the global effort to eliminate Alzheimer’s disease and to recognizing the efforts of researchers who further our understanding about this devastating disease. The Association is the largest nonprofit funder of Alzheimer’s research. It currently supports nearly 350 ongoing research projects in 21 countries, totaling over $78 million. Since 1982, it has awarded nearly $340 million to almost 2,300 scientific investigations.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report's "Best Medical Schools," aligned with a U.S. News & World Report "Honor Roll" Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.